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Increased Anionic Peptide Distribution and Intensity during Progression
and Resolution of Bacterial Pneumonia
Abstract
Anionic peptides (APs) are small anionic antimicrobial peptides composed of 7 aspartic acid residues and are
produced in the lungs of humans, sheep, and cattle. Although expression by epithelial cells of some
antimicrobial peptides (e.g., β-defensins) of humans and ruminants is increased in response to acute infection,
AP expression is not increased during acute infection, which suggests that the expression of the latter peptide
is constitutive. In this study, the degree of AP expression during the progression (acute, subacute, and
chronic) of bronchopneumonia was determined. Mannheimia (Pasteurella) haemolytica, a known inducer of
bovineβ-defensins, was inoculated intrabronchially with a fiber-optic bronchoscope in nine 3-month-old
sheep, and tissues were collected at 1, 15, and 45 days postinoculation (p.i.); nine control animals received
pyrogen-free saline by the same procedure and were killed at the same time points. In the acute group (1 day
p.i.), the lungs had lesions typical of bronchopneumonia and the distribution and intensity of AP
immunoreactivity (AP-IR) were similar to those of previous studies (minimal intensity and distribution of
AP-IR in bronchiolar epithelial cells). In the subacute group (15 days p.i.), there was prominent hyperplasia of
bronchiolar and alveolar epithelial cells, and the chronic group (45 days p.i.) had yet more pronounced
hyperplasia. In the subacute and chronic groups, the intensity and distribution of AP-IR in the cytoplasm of
hyperplastic bronchiolar and type II alveolar cells were significantly increased compared to those of saline-
inoculated and contralateral (noninoculated) lung lobes. Although AP expression appears constitutive, the
constitutive production of AP is higher in hyperplastic, less differentiated cells than in fully differentiated,
mature cells of the respiratory airways. The increased intensity and distribution of AP-IR in immature
(hyperplastic) epithelial cells may be a mechanism by which production of a noninducible antimicrobial is
increased temporarily during lesion progression and repair. This increased production of AP by hyperplastic
cells may protect the lung against further infection until new, fully differentiated epithelial cells are capable of
expressing their own inducible array of antimicrobial peptides.
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Anionic peptides (APs) are small anionic antimicrobial peptides composed of 7 aspartic acid residues and
are produced in the lungs of humans, sheep, and cattle. Although expression by epithelial cells of some anti-
microbial peptides (e.g., -defensins) of humans and ruminants is increased in response to acute infection, AP
expression is not increased during acute infection, which suggests that the expression of the latter peptide is
constitutive. In this study, the degree of AP expression during the progression (acute, subacute, and chronic)
of bronchopneumonia was determined. Mannheimia (Pasteurella) haemolytica, a known inducer of bovine -
defensins, was inoculated intrabronchially with a fiber-optic bronchoscope in nine 3-month-old sheep, and
tissues were collected at 1, 15, and 45 days postinoculation (p.i.); nine control animals received pyrogen-free
saline by the same procedure and were killed at the same time points. In the acute group (1 day p.i.), the lungs
had lesions typical of bronchopneumonia and the distribution and intensity of AP immunoreactivity (AP-IR)
were similar to those of previous studies (minimal intensity and distribution of AP-IR in bronchiolar epithelial
cells). In the subacute group (15 days p.i.), there was prominent hyperplasia of bronchiolar and alveolar epi-
thelial cells, and the chronic group (45 days p.i.) had yet more pronounced hyperplasia. In the subacute and
chronic groups, the intensity and distribution of AP-IR in the cytoplasm of hyperplastic bronchiolar and type
II alveolar cells were significantly increased compared to those of saline-inoculated and contralateral (noni-
noculated) lung lobes. Although AP expression appears constitutive, the constitutive production of AP is higher
in hyperplastic, less differentiated cells than in fully differentiated, mature cells of the respiratory airways. The
increased intensity and distribution of AP-IR in immature (hyperplastic) epithelial cells may be a mechanism
by which production of a noninducible antimicrobial is increased temporarily during lesion progression and
repair. This increased production of AP by hyperplastic cells may protect the lung against further infection
until new, fully differentiated epithelial cells are capable of expressing their own inducible array of antimi-
crobial peptides.
Antimicrobial peptides serve as a part of the innate immune
system of respiratory epithelia, potentially reducing bacterial
numbers nonspecifically and therefore limiting bacterial colo-
nization (9, 11, 13). Some antimicrobial peptides are upregu-
lated in response to lipopolysaccharide and other mediators of
inflammation (9, 10, 14, 18, 19, 21), while others are produced
constitutively (9, 13). Anionic antimicrobial peptides (APs) are
small homopolymeric peptides of 7 aspartic acid residues that
have been detected in the lungs and bronchoalveolar lavage
fluid of humans, sheep, and cattle (5–8). An AP has potent
antimicrobial activity but is distinct from many antimicrobial
peptides for the following reasons: it is smaller in size, it has an
anionic charge due to its being a septamer of aspartate, it has
a requirement for zinc as a cofactor for bactericidal activity,
and it is present in pulmonary surfactants (3, 5, 7). AP may be
a product of posttransitional cleavage of a larger peptide, such
as a zymogen (7); however, the identity of the mature protein
product from which AP is cleaved has not as yet been deter-
mined.
Expression of some antimicrobial peptides by respiratory
epithelia such as human -defensin 2 (20) and bovine -de-
fensins (lingual antimicrobial peptides and tracheal antimicro-
bial peptides) (10, 18, 19, 21) increases in the presence of
pulmonary infection and/or inflammation; however, expression
of these peptides in neonates tends to be limited. Although
expression of AP occurs in neonates, AP expression is likely
constitutive, because AP distribution and intensity are not in-
creased in the lungs of adult humans with pneumonia, children
with or without cystic fibrosis, or cattle with acute pneumonia
caused by Mannheimia haemolytica (6, 8). It is our hypothesis
that AP expression may increase during chronic phases of
pneumonia in immature, regenerative epithelial cells during
the repair of lung injury. Increased expression of a constitu-
tively expressed antimicrobial peptide such as AP may protect
the lung from reinfection during repair and allow time for the
cells to mature in order to express inducible forms of antimi-
crobial peptides such as the -defensins. In this study, we
assess the distribution of AP expression in acute (day 1), sub-
acute (day 15), and chronic (day 45) lesions of M. haemolytica
infection in the lungs of sheep. M. haemolytica is a known
* Corresponding author. Mailing address: Department of Veteri-
nary Pathology, College of Veterinary Medicine, Iowa State Univer-
sity, Ames, IA 50011-1250. Phone: (515) 294-3282. Fax: (515) 294-
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inducer in respiratory epithelia of bovine -defensins (lingual
antimicrobial peptides and tracheal antimicrobial peptides)
(21), whose presence can result in chronic, regenerative lesions
in the lung characterized by hyperplasia of alveolar and bron-
chiolar epithelial cells (1, 12, 15, 17).
MATERIALS AND METHODS
Experimental animals. Eighteen 3-month-old sheep of both sexes and mixed
breeds were obtained from Laboratory Animal Resources, Iowa State University.
The animals were maintained in isolation rooms in accordance with the proce-
dures approved by the American Association of Laboratory Animal Care. After
24 h, the animals were randomly assigned to two groups; one group was admin-
istered doses of M. (Pasteurella) haemolytica, and the other was administered
saline. Subsequently, these groups were subdivided according to the time of
sacrifice at 1, 15, and 45 days postinoculation (p.i.). This arrangement resulted in
six groups, with each group containing three animals.
Inoculation. M. haemolytica (strain 82/25; originally recovered from a natural
case of pneumonic pasteurellosis in sheep) was grown in tryptose broth medium
to 10 CFU/ml (2,4). An inoculum of either bacterial broth or pyrogen-free saline
(5 ml) was deposited into the right cranial lobe bronchus with a fiber-optic
bronchoscope as described previously (2, 4, 16, 17).
Collection of lung samples. Animals were euthanized with an intravenous
overdose of sodium pentobarbital. Lung tissues were collected from the site of
inoculum deposition in the right lungs and additionally from the equivalent site
in the noninoculated (left) lungs from those animals that received the bacterial
inoculum. Two samples of lung per site were collected. Lung tissues were fixed
by immersion in 10% neutral buffered formalin (48 h at room temperature).
Immunohistochemistry. Slides were stained for AP-IR by a previously de-
scribed procedure (6, 8). Briefly, slides were deparaffinized and subjected to
antigen retrieval (microwaved to boiling, simmered for 5 min at near-boiling
temperature in citrate buffer [pH 6.0], and then cooled in a 20°C freezer for 15
min and returned to room temperature). The slides were washed in TNTB buffer
(0.05 M Tris, 0.85% NaCl, 0.05% Tween 20, 1% bovine serum albumin) and then
incubated with the mouse anti-AP immunoglobulin G (IgG) 1G9–1C2 at a
1:1,000 dilution overnight in a humidified chamber at 4°C. 1G9–1C2 was pro-
duced in CF1 mice by using the synthetic peptide H-DDDDDDD-OH conju-
gated to keyhole limpet hemocyanin (5, 7). The following morning, the slides
were warmed to room temperature, rinsed with TNTB buffer, and incubated for
30 min at room temperature with biotinylated goat anti-mouse IgG at a 1:400
dilution (Vector, Burlingame, Calif.). The slides were rinsed in BioGenex wash
buffer, and then supersensitive alkaline phosphatase-conjugated streptavidin
(BioGenex, San Ramon, Calif.) was applied for 30 min. The slides were rinsed
and then exposed to chromogen (Vector Red) for 10 to 18 min, rinsed, coun-
terstained, and coverslipped. Specificities of antibody affinities with tissue sec-
tions were determined by preincubating the primary antibody, 1G9–1C2, with
differing concentrations of up to 0.5 mM synthetic AP (H-DDDDDDD-OH).
Inhibition of 100% of the AP-IR was observed after 1G9–1C2 was preincubated
for 45 min with 25 g of the synthetic target peptide/ml. Other included slides
that were not incubated with primary antibody or nonspecific mouse IgG served
as negative controls. In all control sections, there was no immunoreactivity
except in occasional regions of lungs with small foci of necrotic debris.
Scoring of AP immunohistochemistry. The cellular distribution and intensity
of AP-IR were assessed and characterized by light microscopy. The distributions
of staining of epithelial cells of airways (bronchi and bronchioles) and alveoli
were scored on a subjective scale from five random fields (40 magnification) in
two lung sections, where 0 indicated no AP-IR, 1 indicated that10% of epi-
thelial cells had AP-IR, 2 indicated that 10 to 30% of epithelial cells had AP-IR,
3 indicated that 30 to 60% of epithelial cells had AP-IR, and 4 indicated that 60
to 90% of epithelial cells had AP-IR. The intensities of AP-IR in epithelial cells
were also scored with a subjective scale where 0 indicated no AP-IR, 1 indicated
nuclear staining only; 2 indicated multifocal, mild cytoplasmic, and diffuse nu-
clear staining; 3 indicated diffuse, light red cytoplasmic AP-IR, with or without
nuclear staining; and 4 indicated diffuse, bright red cytoplasmic AP-IR.
Specificity of AP monoclonal antibody. (i) Assessment of antibody specificity.
Antibody specificity was previously assessed by a competitive enzyme-linked
immunosorbent assay (5, 7). Briefly, bovine serum albumin–DDDDDDD-OH
conjugate (50 ng of conjugate/well) was used as the adsorbed antigen and dif-
fering graded concentrations (1.0 to 0.002 mM) of H-DDDDDDD-OH, H-
GADDDDD-OH, H-VDDDDK-OH, H-TQDDGGK-OH, H-GGEEK-OH, and
H-SGSGSGS-OH were used as the competitive antigens in the presence of
1G1–1C2. 1G1–1C2 was specific for peptides with C-terminal Asp residues. The
antibody recognized H-GADDDDD-OH nearly as well as H-DDDDDDD-
OH. However, H-VDDDDK-OH, H-TQDDGGK-OH, H-GGEEK-OH, and H-
SGSGSGS-OH were not recognized.
(ii) Identification of antibody epitopes. The epitope binding site of the mono-
clonal (1G9–1C2) antibody was previously determined in great detail (5, 7).
Thirty peptides (7 residues each) corresponding to a single residue frameshift of
the sequence were synthesized and then screened simultaneously on a derivat-
ized cellulose sheet (SPOTs; Genosys, The Woodlands, Tex.). Antibody 1G9–
1C2 recognized epitopes that contained greater than 2 C-terminal Asp (D) res-
idues.
Statistical analysis. The results of the subjectively scored slide assays were
analyzed by the Kruskal-Wallis test. All calculations were performed with SAS
Institute (Cary, N.C.) statistical software. Results were classified as significant
when P was 0.05.
RESULTS
Gross lesions. Animals that received the bacterial inoculum
had lesions during the acute, subacute, and chronic stages
typical of those caused by M. haemolytica pneumonia. Nonin-
oculated (left) lungs and lungs from all lambs inoculated with
pyrogen-free saline (control) lacked gross lesions.
Microscopic lesions. The lungs of animals in the acute group
(1 day p.i.) that received bacterial broth had extensive areas of
edema, hemorrhage, infiltrates of neutrophils, and necrosis
typical of M. haemolytica pneumonia (1, 12, 17).
In the subacute group (15 days p.i.), histologic lesions of
lung lobes that had received bacterial inoculation were char-
acterized by (i) large foci of caseous necrotic and pyogranulo-
matous chronically dilated bronchi surrounded by lobular, sup-
purative bronchial cells indicative of bronchopneumonia; (ii)
fibrous connective tissue in alveolar septa; (iii) a marked pro-
liferation of large, cuboidal epithelial cells in bronchioles; and
(iv) alveoli and infiltrates of lymphocytes and plasma cells in
large bronchi. There was an underlying pattern of mild inter-
stitial pneumonia and peribronchiolar lymphoid hyperplasia in
all sections of lung examined.
The sections of lungs from the chronic (45 days p.i.) group
had differing degrees of chronic changes, including alveolar
and bronchiolar fibrosis and proliferation of bronchiolar epi-
thelia, accompanied by a marked infiltration of lymphocytes
and plasma cells. In one animal, small airways were surround-
ed by fibrous connective tissue that sometimes encroached on
tortuous bronchioles or even formed organized masses inside
lumena (bronchiolitis fibrosa obliterans). The alveolar and
bronchiolar lumina contained occasional clusters of neutro-
phils and cell debris.
The lungs of control animals lacked microscopic lesions.
However, three animals had mild hyperplasia of peribronchio-
lar lymphoid tissue, with no other significant changes.
AP-IR. AP-IR was mild in bronchioles of the lung lobes
contralateral to inoculated lobes and in the bronchial and
bronchiolar epithelial cells of lambs inoculated with saline
(Fig. 1 and Tables 1 and 2). AP-IR in lambs from the acute
group (1 day p.i.) was similar to that described previously for
acute pneumonia of cattle and sheep (A. J. Fales-Williams,
K. A. Brogden, E. Huffman, J. M. Gallup, and M. R. Acker-
mann, unpublished data). Lung sections from the lambs from
the subacute group (15 days p.i.) had diffuse AP-IR in hyper-
plastic bronchiolar epithelial cells lining alveoli and bronchi-
oles in areas of inflammation. AP-IR was also present in indi-
vidual bronchial and bronchiolar epithelial cells adjacent to the
foci of peribronchial lymphoid hyperplasia. In the remaining,
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noninflamed areas of the lungs, AP-IR was similar to that of
the control sections (contralateral and saline-inoculated
lungs). AP-IR was present in the cuboidal bronchiolar epithe-
lia in regions of bronchioles exhibiting early fibrosis (Fig. 2A),
and prominent AP-IR was present in hyperplastic cells of bron-
chioles and alveoli (Fig. 2B). In the lungs of the lambs in the
chronic group (45 days p.i.), AP-IR was intense in the cyto-
plasm of the bronchiolar epithelial cells in the foci of bronchi-
olitis fibrosa obliterans, as well as in cuboidal-to-columnar
epithelial cells throughout the foci of lobular bronchopneumo-
nia in one lamb with these histologic changes (Fig. 2C). The
intensity of AP-IR in hyperplastic bronchiolar epithelial cells
was greater in the chronic group (45 days p.i.) than the sub-
acute pneumonia group (15 days p.i.). In sections of the con-
tralateral lung lobes from infected animals, there were no foci
of epithelial hyperplasia, other than multifocal epithelial hy-
perplasia adjacent to the foci of lymphoid hyperplasia. In both
the subacute and chronic pneumonia lesions, there was no
AP-IR in hyperplastic bronchiolar epithelia when the tissues
were incubated with nonspecific mouse IgG. Although there
were distinct visual differences in the intensity of AP-IR in the
acute group compared to those of the subacute and chronic
groups, there were no statistical differences in the subjective
scores as determined by the Kruskal-Wallis test; however, the
distribution and intensity of AP-IR were significantly increased
in areas of epithelial cell hyperplasia compared to those of
areas lacking hyperplastic cells (Table 3). In addition, in all
locations where lung tissue showed hyperplastic cells in these
animals, AP-IR was intense and in all areas lacking hyperplas-
tic cells, AP-IR intensity was minimal and similar to that of
controls. Thus, increased AP-IR intensity and distribution oc-
curred only in regions with hyperplastic cells and was consis-
tently present in such cells.
The time points for euthanasia were chosen as representa-
tive of the acute, subacute, and chronic stages of the pneumo-
nic lesions (1, 12, 17). In the present study, all of the changes
characteristic of natural infection were present in the lungs of
animals from all groups. The lesions of mild hyperplasia of
peribronchiolar lymphoid tissue present in lambs of the control
group were likely secondary to Mycoplasma ovipneumoniae
infection (17); however, these changes were minimally present
in both the control and bacterium-inoculated lungs and were
not associated with AP-IR.
DISCUSSION
The mild bronchial and bronchiolar AP-IR in the lungs of
the control animals, as well as in contralateral lung sections
from noninoculated animals, and the lack of increased AP-IR
in the lung tissues from animals with acute pneumonia were
similar to the results for humans, sheep, and cattle in previous
studies (6, 8).
In contrast, the expression of AP in the lung tissues of lambs
with subacute and chronic pneumonia due to infection with M.
(Pasteurella) haemolytica was strikingly increased in the lungs
of animals with subacute-to-chronic bacterial pneumonia. The
increased AP-IR was located in the cytoplasm of hyperplastic
bronchiolar epithelial cells and alveolar type II epithelial cells
of all areas of the lungs of the animals with these cells. This
finding suggests that, while AP expression is not up-regulated
in response to acute inflammation, there is a relative increase
in AP accumulation within the proliferative (hyperplastic) cells
involved in repair. This increase may be due to either increased
basal AP expression, increased cytoplasmic storage, or a lack
of release or secretion of AP by these cells. An enhanced
constitutive production of AP (or its parent zymogen com-
pound) (5, 7) may be an essential part of the biological activity
of hyperplastic regenerative epithelial cells during lesion res-
olution. The mechanism(s) and relevance of the apparent ma-
turity-dependent expression of AP by epithelial cells are un-
known, but AP may serve to protect immature lung epithelial
cells from microbial infection during repair and allow them
time for additional differentation to the point where they can
express the inducible families of antimicrobial peptides.
Although most epithelial cells in normal lungs exhibit AP
expression in the cytoplasm and nucleus, the increased AP in
hyperplastic cells is due to cytoplasmic rather than nuclear
production. AP expression in the cytoplasm is at a location
TABLE 1. Distribution and intensity of AP-IR in lung lobes
contralateral (noninoculated) to inoculated lobesa
No. of days p.i.
(no. of sheep)
AP-IR distribution
score
AP-IR intensity
score
1 (3) 1 1
15 (3) 1 1
45 (3) 1 1
a Distribution and intensity of AP-IR were determined as outlined in Materials
and Methods.
TABLE 2. Distribution and intensity of AP-IR in lung lobes of
sheep inoculated with pyrogen-free salinea
No. of days p.i.
(no. of sheep)
AP-IR distribution score
(range)
AP-IR intensity score
(range)
1 (2) 1.167 (1–1.5) 1.333 (1–2)
15 (3) 1.333 (1–2) 1.333 (1–2)
45 (3) 1 1
a Distribution and intensity of AP-IR were determined as outlined in Materials
and Methods.
FIG. 1. Individual bronchiolar epithelial cells exhibit AP-IR in
lungs 1 day p.i. with saline, while many cells lack AP-IR. Most cells lack
or have only minimal amounts of AP-IR in the cytoplasm. The airways
lack epithelial cells undergoing hyperplasia. Magnification, 20.
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closer to the site of initial microbial adherence and coloniza-
tion. In addition, the cytoplasm also has organelles (e.g., ves-
icles and vacuoles) for immediate release or secretion that are
clearly lacking in the nucleus. Therefore, preferential AP ex-
pression in the cytoplasm rather than the nucleus is another
feature that differs from AP expression by nonhyperplastic
cells and is consistent with AP’s antimicrobial activity. The
identification and characterization of the parent zymogen com-
pound are necessary to understand this and other aspects of
AP. Unidentified 31- and 64-kDa proteins show positive
AP-IR during Western analysis of sheep lung extract.
This study also shows that in this model of M. haemolytica
pneumonia, lesions are located primarily at the site of inocu-
lum deposition, with no compromise of the contralateral, noni-
noculated lung. Bacteria-inoculated animals develop focal le-
sions of pneumonic pasteurellosis that are similar to those seen
in natural infections but do not alter the remaining lobes. The
noninflamed areas had AP-IR identical to that of the corre-
sponding areas of the control animals, which suggests that AP
expression in noninfected areas of lungs is not altered by lo-
calized infections in an animal. The effect of localized lesions
in various stages of pneumonia on the expression of inducible
antimicrobial peptides, such as certain -defensins, has not
been determined.
In summary, this study demonstrates that the distribution of
AP is not altered during the progressive stages of pneumonia
in most bronchi and bronchioles; however, in bronchioles and
alveoli with hyperplastic epithelial cells, there is a marked
increase in the cytoplasmic expression of AP. This expression
may be a general characteristic of hyperplastic respiratory ep-
ithelial cells and may have a role in protection against addi-
tional microbial infections during the resolution and repair of
lesions resultant of bronchopneumonia.
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